Recently, the Shanghai Center for Clinical Laboratory Quality Control announced the results of the first external quality assessment of 2023. The Septin9 gene methylation detection project submitted by Tianjin Baikang Hexin Medical Laboratory—the independently operated clinical trial window under ProteinT—produced results fully consistent with the expected standard values, successfully passing this external quality assessment!
Baikang Hexin Septin9 gene methylation external quality assessment results report
In recent years, liquid biopsy technology has been increasingly widely used in tumor early screening and early diagnosis, efficacy monitoring, and recurrence assessment. Septin9 gene methylation is a specific molecular marker in the early occurrence and development of colorectal cancer. Detecting methylated Septin9 gene fragments in blood can be used for the early auxiliary diagnosis of colorectal cancer. To ensure the accuracy of test results, professional technical proficiency and a rigorous quality management system are indispensable. Actively participating in various external quality assessments is an important way to evaluate a laboratory's quality and capability. ProteinT will uphold an attitude of pursuing excellence and striving for perfection in facing every task and challenge, continuously improve the laboratory's technical level, and provide clinicians and patients with higher-quality testing services.
About Tianjin Baikang Hexin Medical Laboratory
Tianjin Baikang Hexin Medical Laboratory is the independently operated clinical trial window under ProteinT. It is a national high-tech enterprise and a for-profit medical institution approved by the Health Commission, equipped with an Illumina NextSeq 500 sequencing system, Thermo Fisher Q-Exactive+/HF and AB SCIEX 4500 mass spectrometry systems, and a Bruker Avance III IVDr nuclear magnetic resonance spectrometer platform, with a total value of more than RMB 90 million. It has cumulatively served more than 100 tertiary hospitals and research institutions, with a sample volume of over 100,000 cases.
About External Quality Assessment
External Quality Assessment (EQA), also known as proficiency testing, is an internationally recognized important component of comprehensive quality management in clinical laboratories. It is an important tool for health administrative departments and hospital managers to supervise laboratory quality, and plays a very important positive role in ensuring and improving the quality of clinical testing and advancing the standardization of clinical testing.
